Diabetes drug dapagliflozin could also be beneficial for patients with progressive liver disease, a clinical trial has shown.

Around 3,000 lives could be saved and 5,500 hospital admissions prevented each year by changes to how people are treated for heart failure, according to a watchdog. New draft guidelines from the ...

New guidelines for treating heart failure could save 3,000 lives and prevent 5,500 hospital admissions every year, according ...

A drug commonly used to treat type 2 diabetes may also help improve a serious liver condition, according to a new clinical ...

For patients with MASH, treatment with dapagliflozin is beneficial for improvement of MASH without worsening of fibrosis and for improvement of fibrosis without worsening of MASH.